Drosophila melanogaster multisubstrate deoxyribonucleoside kinase (Dm-dNK) can
additionally sensitize human cancer cell lines towards the anti-cancer drug
gemcitabine. We show that this property is based on the Dm-dNK ability to
efficiently phosphorylate gemcitabine. The 2.2A resolution structure of Dm-dNK
in complex with gemcitabine shows that the residues Tyr70 and Arg105 play a
crucial role in the firm positioning of gemcitabine by extra interactions made
by the fluoride atoms. This explains why gemcitabine is a good substrate for
Dm-dNK.